Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • February 2022
  • Case
  • HBS Case Collection

Leading The UK Vaccine Task Force

By: Amy C. Edmondson and Claudia Pienica
  • Format:Print
  • | Language:English
  • | Pages:28
ShareBar

Abstract

This case describes the first six months of the UK Vaccine Taskforce, under the leadership of Kate Bingham. With a career spent in the private sector as a biotech investor, Bingham’s appointment within the government was considered unusual. The overarching brief given to her by the UK Prime Minister was simple: “Stop people from dying.” At that time, however, no vaccine for human coronaviruses had ever been successfully developed, and the average time to take any new vaccine to market was over ten years. Furthermore, the UK had a relatively weak market position. Bingham assembled a senior leadership team of private sector experts and civil servants with the skills required to think about how to make vaccines, test them, deliver them, and build long-term resiliency into the system. Beyond building a diversified portfolio of vaccine candidates, the team took a commercial approach and aimed to make the UK the best global client possible. While there were some frictions due to the unusual setup of the taskforce, the team's work was an unequivocal success. The UK became the first country to approve and administer a COVID-19 vaccine outside of a clinical trial context, and had placed its bets on safe and effective vaccines.

Keywords

COVID-19; Vaccine; Government; Health Pandemics; Health Care and Treatment; Science; Innovation and Invention; Groups and Teams; Leadership; Decision Making; Government and Politics; Health; Innovation and Management; Governance; Change; Government Administration; Health Industry; Financial Services Industry; Public Administration Industry; Europe; United Kingdom

Citation

Edmondson, Amy C., and Claudia Pienica. "Leading The UK Vaccine Task Force." Harvard Business School Case 622-079, February 2022.
  • Educators
  • Purchase

About The Author

Amy C. Edmondson

Technology and Operations Management
→More Publications

More from the Authors

    • January–February 2023
    • Harvard Business Review

    Rethink Your Employee Value Proposition: Offer Your People More Than Just Flexibility

    By: Mark Mortensen and Amy C. Edmondson
    • November 2022
    • Faculty Research

    Executive Decision-Making at Zola

    By: Amy C. Edmondson and Michael Roberto
    • July 2022 (Revised November 2022)
    • Faculty Research

    Building a Mishap-Free U.S. Navy

    By: Amy C. Edmondson, Herman B. Leonard, Michael W. Toffel and Michael Norris
More from the Authors
  • Rethink Your Employee Value Proposition: Offer Your People More Than Just Flexibility By: Mark Mortensen and Amy C. Edmondson
  • Executive Decision-Making at Zola By: Amy C. Edmondson and Michael Roberto
  • Building a Mishap-Free U.S. Navy By: Amy C. Edmondson, Herman B. Leonard, Michael W. Toffel and Michael Norris
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College